Traditional Chinese medicine composition for treating canine parvovirus disease, extracting solution of traditional Chinese medicine composition and medicine containing extracting solution

By using the extract of specific traditional Chinese medicine compositions, the problem of poor treatment effect of canine parvovirus disease in the prior art was solved, and the effect of significantly improving the cure rate and shortening the course of the disease was achieved without side effects.

CN118949000AActive Publication Date: 2024-11-15ZHENGZHOU SAIKE PHARM TECH CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411123191.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-15
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

There is a lack of effective methods for treating canine parvovirus disease in the prior art, especially due to the unstable effect of vaccines and antibodies, which makes it difficult to completely solve the disease, and common antibiotics have brought about drug resistance problems.

Method used

Provided is a traditional Chinese medicine composition, including Orchidaceae, Purslane, Pinellia, Scutellaria baicalensis, Pinellia ternata, Pueraria scutellaria, Pueraria root, Sophora, Dried ginger, Ginseng and Licorice, and prepared into oral liquid agents by specific extraction and compatibility methods. , used to treat canine parvovirus disease.

Benefits of technology

It significantly improved the cure rate of canine parvovirus disease, shortened the course of the disease, reduced the number of days of vomiting and bloody dysentery, and showed safe and effective treatment effects in animal trials without side effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention belongs to the field of animal medicine, particularly relates to a traditional Chinese medicine composition for treating canine parvovirus disease, and also relates to a corresponding extracting solution and a medicine containing the extracting solution. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 10-35 parts of cacumen biotae, 10-35 parts of herba portulacae, 10-35 parts of herba andrographitis, 10-25 parts of radix sanguisorbae, 10-25 parts of radix scutellariae, 10-25 parts of rhizoma pinelliae, 10-20 parts of radix puerariae, 10-15 parts of flos sophorae, 10-15 parts of rhizoma zingiberis, 5-15 parts of radix ginseng and 5-15 parts The medicine comprises the following components in percentage by weight: 1-3% of vitamin B complex, 5-20% of beef enzymatic hydrolysate, 0.3% of preservative, 0.1% of sweetening agent and the balance of extracting solution of the traditional Chinese medicine composition for treating canine parvovirus disease. The extracting solution of the traditional Chinese medicine composition can be used for preparing oral medicine for treating the canine parvovirus disease, and the oral medicine has no side effect and no medicine residue through strict traditional Chinese medicine compatibility and taste debugging, so that the purpose of safely and effectively curing the canine parvovirus disease is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of animal medicine, and in particular relates to a traditional Chinese medicine composition for treating canine parvovirus disease, and also relates to a corresponding extract and a medicine containing the extract. Background Art

[0002] Canine parvovirus disease is an acute infectious disease caused by canine parvovirus (CPV) infecting dogs, characterized by hemorrhagic enteritis. Dogs of all ages, genders, and breeds are susceptible to infection. The main sources of infection are infected dogs and carriers, which excrete toxins through urine, feces, saliva, or vomit, which can easily cause contamination of food, drinking water, and utensils, leading to infection. Among them, young, unvaccinated dogs are most susceptible and have the characteristics of outbreaks in the same litter. The main symptoms of infected dogs are severe vomiting, hemorrhagic diarrhea, dehydration, and a significant decrease in leukocytes. It is one of the common clinical diseases. The mortality rate of infected puppies is as high as 50% to 100%. It develops rapidly and is one of the most serious infectious diseases that endanger dogs.

[0003] Since the disease develops rapidly and has a short course, untimely treatment will lead to the death of the dog. There is no specific treatment yet, and the treatment is mainly symptomatic according to the condition of the dog, generally based on fluid replacement, with the addition of high-immune serum or monoclonal antibody therapy, antibiotic treatment, injection of interferon, etc. In addition, the effects of vaccines, high-immune serum, monoclonal antibodies, etc. used to prevent and treat canine parvovirus are uneven, and the effect of high-immune serum has also been declining year by year. Vaccines and antibodies have certain limitations, and various antibiotics used for auxiliary treatment also bring a series of problems such as drug resistance, making the development of new, highly effective, non-toxic and side-effect-free Chinese medicine compositions against canine parvovirus disease a new research topic. Summary of the invention

[0004] In view of the problems and shortcomings in the prior art, the present invention provides a Chinese medicine composition for treating canine parvovirus disease, and also provides an extract prepared by using the Chinese medicine composition and a medicine containing the extract.

[0005] Based on the above purpose, the present invention adopts the following technical solution:

[0006] In the first aspect, the present invention provides a traditional Chinese medicine composition for treating canine parvovirus disease, which comprises the following components, by weight, 10 to 35 parts of Platycladus orientalis leaves, 10 to 35 parts of Portulaca oleracea, 10 to 35 parts of Andrographis paniculata, 10 to 25 parts of Sanguisorba officinalis, 10 to 25 parts of Scutellaria baicalensis, 10 to 25 parts of Pinellia ternata, 10 to 20 parts of Pueraria root, 10 to 15 parts of Sophora japonica flower, 10 to 15 parts of dried ginger, 5 to 15 parts of ginseng, and 5 to 15 parts of licorice.

[0007] Preferably, the following components are included, by weight: 25-30 parts of Platycladus orientalis leaves, 25-30 parts of Portulaca oleracea, 25-30 parts of Andrographis paniculata, 15-20 parts of Sanguisorba officinalis, 15-20 parts of Scutellaria baicalensis, 15-20 parts of Pinellia ternata, 13-17 parts of Pueraria root, 10-15 parts of Sophora japonica flowers, 10-15 parts of dried ginger, 5-10 parts of ginseng, and 5-10 parts of liquorice.

[0008] In a second aspect, the present invention provides an extract of a traditional Chinese medicine composition for treating canine parvovirus disease, comprising:

[0009] (A) Andrographis paniculata extract, which is an ethanol extract of Andrographis paniculata, wherein the weight volume ratio of the ethanol extract of Andrographis paniculata to Andrographis paniculata is 1 ml:2 g;

[0010] (B) Scutellaria baicalensis extract, which is a solution obtained by dissolving baicalin, a product of water extraction and acid precipitation of Scutellaria baicalensis, in 8 times the concentration of 50% ethanol solution and adjusting the pH value to neutral, wherein the weight volume ratio of the solution to Scutellaria baicalensis is 1 ml:2 g;

[0011] (C) water extracts of Platycladus orientalis leaves, Portulaca oleracea, Sanguisorba officinalis, Pinellia tuber, Pueraria root, Sophora japonica flower, Dry ginger, Ginseng, and Licorice, wherein the weight volume ratio of the water extract to the corresponding medicinal flavor is 1 ml:2 g;

[0012] The Andrographis paniculata extract of component A and the Scutellaria baicalensis extract of component B are added to the water extract of component C, mixed evenly, and the pH value is adjusted to 5.5-6.0 to obtain the extract of the traditional Chinese medicine composition for treating canine parvovirus disease.

[0013] Preferably, the Andrographis paniculata extract of component A is extracted by the following steps: placing Andrographis paniculata in an ethanol solution with a concentration of 80V% for immersion extraction to obtain an immersion solution; decompressing and concentrating the immersion solution to 5% to 10% of the original volume, then decolorizing and filtering, and decompressing and concentrating the filtrate to obtain the Andrographis paniculata extract.

[0014] Furthermore, the specific process of the immersion extraction is: adding Andrographis paniculata to 8-10 times ethanol solution and immersing it for 24 hours, taking it out and adding it to 6-8 times ethanol solution and immersing it for 24 hours, and combining the two immersion solutions.

[0015] Furthermore, the decolorization is carried out by heating and refluxing activated carbon for 30 minutes, and the amount of activated carbon used is 10% to 20% of the weight of Andrographis paniculata.

[0016] Furthermore, the specific process of the filtration is: filtering and collecting the filtrate and filter residue, washing the filter residue twice with 50-70° C. anhydrous ethanol and collecting the washing liquid, and combining the filtrate and the washing liquid.

[0017] Preferably, the scutellaria baicalensis extract of component B is prepared by the following steps:

[0018] Add 8-10 times water to the scutellaria baicalensis and boil it for 2 hours, and filter it; add 6-8 times water to the dregs and boil it for 2 hours, and filter it; combine the filtrates from the two decoctions, and concentrate them under reduced pressure to 5%-10% of the original volume, then filter and collect the filtrate, add acid to adjust the pH value to 1-2, keep it warm at 80°C for 30 minutes, cool it to precipitate crystals, and obtain crude baicalin;

[0019] The crude baicalin was dissolved in 8 times water, the pH value was adjusted to 7, filtered, the filtrate was collected, acid was added to the filtrate to adjust the pH value to 1-2, the mixture was kept at 50°C for 30 minutes, cooled to precipitate crystals, and baicalin was obtained;

[0020] Add 8 times the concentration of 50V% ethanol solution to baicalin to dissolve it, adjust the pH value to 7, filter, collect the filtrate, and concentrate under reduced pressure to obtain the scutellaria baicalensis extract.

[0021] Furthermore, the acid is added to adjust the pH value to 1-2, and hydrochloric acid solution is used.

[0022] Furthermore, the pH value is adjusted to 7 using a sodium hydroxide solution with a concentration of 40%.

[0023] Preferably, the aqueous extract of component C is prepared by the following steps: taking Platycladus orientalis leaves, Portulaca oleracea, Sanguisorba officinalis, Pinellia tuber, Pueraria root, Sophora japonica flower, dried ginger, ginseng, and licorice in weight ratio, adding 8 to 10 times of water, decocting for 2 hours, and filtering; adding 6 to 8 times of water to the residues, decocting for 2 hours, and filtering; combining the filtrates from the two decoctions, and concentrating under reduced pressure to obtain the aqueous extract of component C.

[0024] In a third aspect, the present invention provides a drug for treating canine parvovirus disease, which is in the form of an oral liquid dosage form, comprising an extract of the traditional Chinese medicine composition for treating canine parvovirus disease described in the second aspect and pharmaceutically acceptable excipients.

[0025] Preferably, the weight percentage composition of the drug is: 1% to 3% of complex vitamin B, 5% to 20% of beef enzymatic hydrolysate, 0.3% of preservative, 0.1% of sweetener, and the rest is the extract of the traditional Chinese medicine composition for treating canine parvovirus disease described in the second aspect.

[0026] Furthermore, the preservative is at least one of sodium benzoate, potassium sorbate, and sodium paraben, and the sweetener is at least one of aspartame and acesulfame potassium.

[0027] Preferably, the drug is prepared by the following method: adding vitamin B complex, beef enzymatic hydrolysate, preservatives, and sweeteners to the extract of the traditional Chinese medicine composition for treating canine parvovirus disease described in the second aspect, mixing thoroughly, and then centrifuging and irradiating to sterilize, thereby obtaining the drug for treating canine parvovirus disease.

[0028] Preferably, the centrifugal speed is 10000 rpm and the time is 10 min.

[0029] All components in the Chinese medicine composition of the present invention can be purchased from the market.

[0030] In the formula,

[0031] Platycladus orientalis leaf: main drug, bitter, astringent, cold. Enters the lung, liver, spleen meridians. Has the effects of cooling blood and stopping bleeding, resolving phlegm and relieving cough, and promoting hair growth and darkening hair. Used for hematemesis, epistaxis, hemoptysis, blood in stool, metrorrhagia, cough due to lung heat, hair loss due to blood heat, and premature graying of hair.

[0032] Purslane: Solitary drug, sour, cold. Enters the liver and large intestine meridians. Has the functions of clearing away heat and detoxifying, cooling blood and stopping bleeding, and stopping dysentery. Used for heat-toxic bloody dysentery, carbuncle, furuncle, eczema, erysipelas, snake and insect bites, blood in stool, hemorrhoids, and metrorrhagia.

[0033] Andrographis paniculata: Sole medicine, bitter, cold, enters the heart, lung, bladder, and large intestine meridians. It has the functions of clearing away heat and detoxifying, reducing swelling and relieving pain; it is mainly used to treat colds and fever, damp-heat diarrhea, sores, carbuncle, furuncle, etc.

[0034] Sanguisorba officinalis: A ministerial drug, sour, bitter, astringent, slightly cold, belonging to the liver and large intestine meridians. It has the functions of cooling blood, detoxifying, stopping bleeding and healing sores; it is mainly used to treat bloody dysentery, epistaxis, uterine bleeding, sores, yellow furuncle poison, etc. It can enhance and protect the function of the hematopoietic system, increase peripheral blood white blood cells, neutrophils, and platelets. It improves bone marrow microcirculation, and regulates and improves the body's immune function.

[0035] Scutellaria baicalensis: ministerial drug, bitter, cold. Enters the lung, gallbladder, spleen, large intestine, small intestine meridians. Has the functions of clearing away heat and dampness, purging fire and detoxifying, stopping bleeding, and calming the fetus. Indications: damp-heat, summer-heat, chest tightness, nausea, damp-heat fullness, diarrhea, etc.

[0036] Pinellia: A ministerial drug, pungent, warm; toxic. Enters the spleen, stomach, and lung meridians. Has the effects of drying dampness and resolving phlegm, lowering adverse qi and stopping vomiting, and dissolving lumps and dispersing masses. Used for damp phlegm and cold phlegm, cough, asthma, excessive phlegm, phlegm and fluid, dizziness and palpitations, wind phlegm, dizziness, phlegm and syncope, headache, vomiting and nausea, etc.

[0037] Pueraria root: adjuvant, sweet, pungent, cool. Enter the spleen, stomach, and lung meridians. It has the effects of relieving muscle and reducing fever, promoting body fluid and quenching thirst, clearing rashes, raising yang and stopping diarrhea. It is mainly used to treat exogenous fever and headache, stiff neck and back pain, thirst, thirst, measles that do not clear up, heat dysentery, diarrhea, etc.

[0038] Sophora japonica: adjuvant, bitter, slightly cold. Enters the liver and large intestine meridians. Has the effects of cooling blood and stopping bleeding, clearing the liver and purging fire. Used for blood in stool, hemorrhoids, bloody diarrhea, metrorrhagia, hematemesis, epistaxis, liver heat and red eyes, headache and dizziness.

[0039] Dried ginger: adjuvant, pungent, hot. Enters the spleen, stomach, kidney, heart, and lung meridians. Has the effects of warming the middle and dispelling cold, restoring yang and unblocking meridians, warming the lungs and transforming fluid. Indications: cold pain in the abdomen, vomiting and diarrhea, cold limbs and weak pulse, asthma and cough due to cold fluid.

[0040] Ginseng: a herb that is sweet, slightly bitter, and slightly warm. It enters the spleen, lung, heart, and kidney meridians. It has the effects of greatly replenishing vital energy, restoring the pulse and strengthening the body, replenishing the spleen and lungs, promoting the production of body fluids and nourishing blood, and calming the mind and improving intelligence. It is mainly used to treat weakness and collapsing, cold limbs and weak pulse, poor appetite due to spleen deficiency, wheezing and coughing due to lung deficiency, thirst due to loss of body fluids, internal heat and thirst, and deficiency of qi and blood.

[0041] Licorice: Envoy, sweet, neutral. Enters the heart, lung, spleen, and stomach meridians. Has the functions of tonifying the spleen and replenishing qi, clearing away heat and detoxifying, removing phlegm and relieving cough, relieving urgency and relieving pain, and harmonizing various medicines. Mainly used to treat spleen and stomach weakness, fatigue, palpitations and shortness of breath, cough with sputum, cramps and pain in the abdomen and limbs, etc.

[0042] Compared with the prior art, the present invention has the following beneficial effects:

[0043] 1. The drug prescription of the present invention is used for clearing away heat and detoxicating, stopping bleeding and cooling blood, and stopping vomiting. Among them, Platycladus orientalis (cooling blood and stopping bleeding), Portulaca oleracea (clearing heat and detoxicating, cooling blood and stopping bleeding), and Andrographis paniculata (clearing heat and detoxicating) are monarch drugs, and the three complement each other and play a major therapeutic effect together. Sanguisorba officinalis (cooling blood and stopping bleeding) and Scutellaria baicalensis (clearing heat and drying dampness, purging fire and detoxicating) are ministerial drugs, which assist the monarch drug in strengthening the effects of clearing heat and detoxicating, cooling blood and stopping bleeding. Pinellia tuber (drying dampness and resolving phlegm, stopping vomiting), Pueraria root (relieving muscle and reducing fever), Sophora japonica (cooling blood and stopping bleeding), and dried ginger (warming the middle and dispersing cold) are adjuvant drugs, among which Pinellia tuber and dried ginger are used to treat vomiting symptoms, Sophora japonica is used to assist the monarch and ministerial drugs in playing the effect of cooling blood and stopping bleeding, and Pueraria root has the effect of raising yang. Ginseng (replenishing vital energy) and Licorice (harmony of various drugs) are guiding drugs, and Ginseng has the effect of enhancing the overall efficacy, and Licorice can harmonize various drugs, which helps each drug to play a synergistic effect.

[0044] 2. The drug of the present invention has significant effects in animal experiments. In the test examples, compared with the Western medicine group, the combination of Chinese and Western medicine can significantly improve the cure rate of canine parvovirus disease, shorten the course of the disease, and reduce the number of days for dogs to stop bloody diarrhea and vomiting, indicating that the oral drug solution of the present invention has a certain effect on the treatment of canine parvovirus disease.

[0045] 3. The oral medicine of the present invention has been strictly prepared with traditional Chinese medicine and its taste has no side effects and no drug residue, thus achieving the purpose of safely and effectively curing canine parvovirus disease. BRIEF DESCRIPTION OF THE DRAWINGS

[0046] Figure 1 This is a picture of the colloidal gold test results of a dog that is positive for canine parvovirus;

[0047] Figure 2 This is a picture of the feces of a dog suffering from canine parvovirus and bloody diarrhea. DETAILED DESCRIPTION

[0048] The following examples are only for further explanation of the present invention. It should be noted that all technical and scientific terms used in the present invention have the same meanings as in the technical field to which the present invention belongs unless otherwise specified. The experimental methods in the following examples without specifying specific conditions are all based on conventional techniques in the technical field, or according to the conditions recommended by the manufacturer; the reagents or instruments used without specifying the manufacturer are all conventional products that can be purchased commercially.

[0049] In order to make the purpose, technical solution and advantages of the present invention clearer and more specific, the present invention is further described in detail by examples below. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0050] Example 1

[0051] The extract of the Chinese medicine composition for treating canine parvovirus disease is obtained by extracting the Chinese medicine composition of different weight portions shown in Table 1:

[0052] Table 1 Chinese medicine compositions of different weight portions

[0053] Chinese medicine composition 1 Chinese medicine composition 2 Chinese medicine composition 3 Platycladus orientalis leaves 30 servings 10 servings 35 servings purslane 30 servings 10 servings 35 servings Andrographis paniculata 25 servings 10 servings 35 servings Sanguisorba officinalis 20 servings 10 servings 25 servings Scutellaria baicalensis 20 servings 10 servings 25 servings Pinellia 20 servings 10 servings 25 servings Pueraria root 15 servings 10 servings 20 servings Sophora japonica 12 servings 10 servings 15 servings Dried ginger 12 servings 10 servings 15 servings Ginseng 10 servings 5 servings 15 servings Licorice 10 servings 5 servings 15 servings

[0054] The Chinese medicine composition in Table 1 was extracted according to the following method to prepare the corresponding extract:

[0055] (1) Adding 10 times the concentration of 80% by volume ethanol solution to Andrographis paniculata and immersing it for 24 hours, filtering and then adding 8 times the concentration of 80% by volume ethanol solution to immerse it for 24 hours, combining the two immersion solutions, and concentrating the immersion solution under reduced pressure to 5% of the original volume, and then decolorizing it by heating and refluxing with activated carbon for 30 minutes, wherein the amount of activated carbon used is 15% of the mass of Andrographis paniculata. After the decolorization is completed, filtering is performed, and the filtrate and filter residue are collected. The filter residue is washed twice with 60° C. anhydrous ethanol and the washing liquid is collected. The filtrate and washing liquid are mixed and then concentrated under reduced pressure to obtain an Andrographis paniculata extract, wherein the ratio of Andrographis paniculata extract to Andrographis paniculata is 1 ml:2 g;

[0056] (2) Add 10 times the amount of water to the Radix Scutellariae and boil it for 2 hours, filter it, add 8 times the amount of water to the residue and boil it for 2 hours, filter it, combine the filtrates from the two decoctions, concentrate it under reduced pressure to 5% of the original volume, then filter and collect the filtrate, add hydrochloric acid solution to the filtrate, adjust the pH value to 1.5, keep it at 80°C for 30 minutes, cool it to precipitate crystals, and obtain crude baicalin; add 8 times the amount of water to dissolve the crude baicalin, adjust the pH value to 7 with a 40% sodium hydroxide solution, then filter and collect the filtrate, add hydrochloric acid solution to the filtrate, adjust the pH value to 1.5, keep it at 50°C for 30 minutes, cool it to precipitate crystals, and obtain baicalin; add 8 times the amount of 50V% ethanol solution to baicalin, adjust the pH value to 7 with a 40% sodium hydroxide solution, then filter and collect the filtrate, and concentrate it under reduced pressure to obtain a baicalin extract, the ratio of the baicalin extract to the Radix Scutellariae is 1 ml:2 g;

[0057] (3) Mix Platycladus orientalis leaves, Portulaca oleracea, Sanguisorba officinalis, Pinellia ternata, Pueraria root, Sophora japonica flower, dried ginger, ginseng and liquorice to obtain a Chinese medicine mixture, add 10 times the amount of water to the Chinese medicine mixture and boil it for 2 hours, and filter it; add 8 times the amount of water to the medicinal residue and boil it for 2 hours, filter it, combine the filtrates from the two decoctions, and concentrate under reduced pressure to obtain a mixed extract, wherein the ratio of the mixed extract to the Chinese medicine mixture is 1 ml:2 g; add the Andrographis paniculata extract obtained in step (1) and the Scutellaria baicalensis extract obtained in step (2) to the mixed extract, mix well, and adjust the pH value to 5.5 to obtain extracts of the Chinese medicine composition for treating canine parvovirus disease, which are labeled as extract 1, extract 2 and extract 3, respectively, corresponding to the compositions in Table 1.

[0058] Example 2

[0059] With reference to the composition listed in Table 2, a drug for treating canine parvovirus disease in the form of an oral liquid is prepared, and the preparation method is as follows:

[0060] Add vitamin B complex, beef enzymatic hydrolysate, preservatives and sweeteners to the extract, mix thoroughly, and then centrifuge at 10000 rpm for 10 minutes. After the centrifugation, sterilize by irradiation to obtain a drug for treating canine parvovirus disease.

[0061] Table 2 Preparation of oral liquids with different weight percentages

[0062] Sample 1 Sample 2 Sample 3 Extract Extract 1, 87.6% Extract 2, 76.6% Extract 3, 93.6% Vitamin B Complex 2% 3% 1% Beef enzymatic hydrolysate 10% 20% 5% preservative 0.3% 0.3% 0.3% Sweeteners 0.1% 0.1% 0.1%

[0063] In Table 2, the vitamin B complex is an aqueous solution, and each ml contains 2 mg of vitamin B1, 0.5 mg of vitamin B2, 0.3 mg of vitamin B6, 3 mg of niacinamide, and 0.4 mg of sodium dextropantothenate.

[0064] In order to verify the therapeutic effect of drugs for treating canine parvovirus disease on canine parvovirus disease, the following animal experiments were conducted.

[0065] Test Example 1:

[0066] 1. Experimental subjects and groups

[0067] Sick dogs (all small dogs, under 12 months old, confirmed cases with positive CPV test) admitted to multiple animal hospitals in Henan Province (Zhengzhou, Xingyang, Nanyang, Luoyang, etc.) from January 2022 to June 2024 were selected. The clinical manifestations on the day of admission were mainly mild diarrhea, vomiting, etc., without symptoms of myocarditis. The above dogs were divided into groups for treatment, including 20 dogs in the Western medicine group and 20 dogs in the combination of Chinese and Western medicine group.

[0068] 2. Experimental Plan

[0069] Western medicine group: infusion therapy, 0.9% saline (20mL / kg) + hemostatic (0.2mL / kg) + 50% glucose (1mL / kg), 5% glucose (20mL / kg) + omeprazole (2mg / kg), 1 to 2 times a day, subcutaneous injection, ampicillin sodium (20mg / kg), canine parvovirus monoclonal antibody (1ml / kg), once a day.

[0070] Chinese and Western medicine combined group: infusion treatment, 0.9% saline (20mL / kg) + hemostatic (0.2mL / kg) + 50% glucose (1mL / kg), 5% glucose (20mL / kg) + omeprazole (2mg / kg), 1 to 2 times a day, subcutaneous injection, ampicillin sodium (20mg / kg), canine parvovirus monoclonal antibody (1ml / kg), once a day, oral administration: oral solution of sample 1 (≤5kg, 5ml each time; 5-10kg, 10ml each time), twice a day.

[0071] 3. Experimental indicators

[0072] The cure rate (cure rate (%) = number of cured animals ÷ number of cases (animals) × 100%), average treatment days, cessation of bloody diarrhea, and cessation of vomiting of experimental animals in the Western medicine group and the combined Chinese and Western medicine group were statistically analyzed.

[0073] 4. Experimental Results

[0074] The cure rate and average treatment days of the experimental animals of Sample 1 are shown in Table 3.

[0075] Table 3 Cure rate and average treatment days of experimental animals of sample 1

[0076] Group Number of cases Number of cures Cure rate Average treatment days Western medicine group 20 15 75% 6.33±0.62 Chinese and Western medicine combination group 20 18 90% 5.33±0.69

[0077] As can be seen from Table 3, the cure rate of the Western medicine group for 20 dogs with parvovirus disease was 75%, and the cure rate of the combined Chinese and Western medicine group for 20 dogs with parvovirus disease after adding Chinese medicine oral liquid was 90%. It can be seen that the course of disease in the combined Chinese and Western medicine group was shorter than that in the Western medicine group, and there was a significant difference in the average number of treatment days between the Western medicine group and the combined Chinese and Western medicine group.

[0078] The results of stopping bloody diarrhea in the experimental animals of Sample 1 are shown in Table 4.

[0079] Table 4 Results of stopping bloody diarrhea in experimental animals of sample 1

[0080]

[0081] As can be seen from Table 4, the number of days taken to stop bloody diarrhea in dogs in the Western medicine group and the combination of Chinese and Western medicine group was 0% in the Western medicine group and 11.1% in the combination of Chinese and Western medicine; 46.7% in the Western medicine group and 61.1% in the combination of Chinese and Western medicine; 53.3% in the Western medicine group and 27.8% in the combination of Chinese and Western medicine; the average number of days taken to stop bloody diarrhea in dogs in the Western medicine group was 4.80 days and 3.83 days in the combination of Chinese and Western medicine. It can be seen that there is a significant difference in the number of days taken to stop bloody diarrhea between the Western medicine group and the combination of Chinese and Western medicine group (P<0.05).

[0082] The results of stopping vomiting in the experimental animals of Sample 1 are shown in Table 5.

[0083] Table 5 Results of stopping vomiting in experimental animals of sample 1

[0084]

[0085] As can be seen from Table 5, the number of days taken to stop vomiting in dogs in the Western medicine group and the combination of Chinese and Western medicine group was 0% in the Western medicine group and 11.1% in the combination of Chinese and Western medicine group; 53.3% in the Western medicine group and 77.8% in the combination of Chinese and Western medicine group; 46.7% in the Western medicine group and 11.1% in the combination of Chinese and Western medicine group; the average number of days taken to stop vomiting in dogs in the Western medicine group was 4.53 days and 3.67 days in the combination of Chinese and Western medicine group. It can be seen that there is a significant difference in the number of days taken to stop vomiting between the Western medicine group and the combination of Chinese and Western medicine group (P<0.05).

[0086] Combined with the clinical trial data, it is shown that compared with the Western medicine group, the combination of Chinese and Western medicine can significantly improve the cure rate of canine parvovirus disease, shorten the course of the disease, and reduce the number of days for dogs to stop bloody diarrhea and vomiting, indicating that the drug oral liquid sample 1 prepared in Example 2 has a certain effect on the treatment of canine parvovirus disease.

[0087] Test Example 2:

[0088] 1. Experimental subjects and groups

[0089] There were 5 animals in the western medicine group (from Zhengzhou and Nanyang pet hospitals): Teddy Qiuqiu, 2 months, 1kg, male, unvaccinated, body temperature 38.4℃, complained that he had just bought it from the market for about three days and found mild vomiting, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper was positive. Pomeranian Dantan, 3 months, 1.2kg, female, vaccinated with 1 shot, body temperature 38.2℃, complained that he had mild diarrhea after taking the pet out to play recently, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper was positive. Bichon Doudou, 2 months, 1.1kg, female, unvaccinated, body temperature 38.3℃, complained that the pet was in poor spirits recently, and found mild vomiting and diarrhea, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper was positive. Corgi Xiaoqi, 1.5 months, 0.9 kg, male, unvaccinated, body temperature 38.1℃, complained of poor spirits recently, diarrhea and vomiting, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper test was positive. Teddy bean curd, 2 months old,

[0090] 1.2kg, male, unvaccinated, temperature 38.3℃, complained of poor appetite recently, suspected of overeating, and slight vomiting, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper was positive.

[0091] There were 5 animals in the combination of Chinese and Western medicine group (from Xingyang and Luoyang pet hospitals): Teddy Mango, 3 months, 2kg, male, vaccinated with 1 shot, body temperature 38.3℃, complained of mild vomiting recently, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper was positive. Teddy Xiaomei, 2 months, 1.1kg, female, unvaccinated, body temperature 38.4℃, complained of mild vomiting recently, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper was positive. Pomeranian Liuliu, 1.5 months, 0.8kg, male, unvaccinated, body temperature 38.0℃, complained of mild diarrhea recently, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper was positive. Bichon Xionger, 2 months, 1.2kg, male, unvaccinated, body temperature 38.4℃, complained of mild vomiting recently, so he came to the hospital for examination, and the canine parvovirus colloidal gold test paper was positive. The pastoral dog Pudding, 2 months old, 1.5 kg, female, unvaccinated, with a body temperature of 38.4℃, complained of mild diarrhea recently, so she came to the hospital for examination and the canine parvovirus colloidal gold test paper test was positive.

[0092] The colloidal gold test results of the above experimental animals for canine parvovirus were as follows: Figure 1 As shown in the figure, the feces of dogs with bloody diarrhea are judged as follows Figure 2 shown.

[0093] 2. Experimental Plan

[0094] Western medicine group: infusion therapy, 0.9% saline (20mL / kg) + hemostatic (0.2mL / kg) + 50% glucose (1mL / kg), 5% glucose (20mL / kg) + omeprazole (2mg / kg), 1 to 2 times a day, subcutaneous injection, ampicillin sodium (20mg / kg), canine parvovirus monoclonal antibody (1ml / kg), once a day.

[0095] Chinese and Western medicine combination group: infusion therapy, 0.9% saline (20mL / kg) + hemostatic (0.2mL / kg) + 50% glucose (1mL / kg), 5% glucose (20mL / kg) + omeprazole (2mg / kg), 1 to 2 times a day, subcutaneous injection, ampicillin sodium (20mg / kg), canine parvovirus monoclonal antibody (1ml / kg), once a day, oral administration: the drug oral solution prepared in Example 2 (≤5kg, 5ml each time; 5-10kg, 10ml each time), twice a day, the sample numbers of the specific dog oral drugs are shown in Table 6.

[0096] 3. Experimental indicators

[0097] The 7-day routine blood data of the experimental animals in the Western medicine group and the Chinese and Western medicine combined group were collected and analyzed respectively.

[0098] 4. Experimental Results

[0099] The results of the 7-day routine blood test data of the experimental animals in Experimental Example 2 are shown in Table 6.

[0100] Table 6 7-day blood routine data results of experimental animals in Experimental Example 2

[0101]

[0102]

[0103]

[0104]

[0105] As can be seen from Table 6, the dog Teddy Qiuqiu in the western medicine group stopped bloody diarrhea and vomiting after 4 days of treatment, and the blood routine returned to normal range on the 6th day. After 7 days of treatment, the dog recovered and was discharged from the hospital; the dog Pomeranian Egg Tart stopped bloody diarrhea and vomiting after 4 days of treatment, and the blood routine returned to normal range on the 5th day. After 7 days of treatment, the dog recovered and was discharged from the hospital; the dog Bichon Doudou stopped bloody diarrhea and vomiting after 4 days of treatment, and the blood routine returned to normal range on the 6th day. After 7 days of treatment, the dog recovered and was discharged from the hospital; the dog Corgi Xiaoqi stopped vomiting after 5 days of treatment, stopped bloody diarrhea after 6 days, and the blood routine returned to normal range on the 7th day. After 7 days of treatment, the dog recovered and was discharged from the hospital; the dog Teddy Chuan Doubao stopped vomiting after 4 days of treatment, stopped bloody diarrhea after 6 days, and the blood routine returned to normal range on the 7th day. After 7 days of treatment, the dog recovered and was discharged from the hospital.

[0106] In the combined Chinese and Western medicine group, the dog Teddy Mango stopped bloody diarrhea and vomiting after 2 days of treatment, and the blood routine returned to normal range on the 5th day. After 7 days of treatment, the dog recovered and was discharged from the hospital; the dog Teddy Xiaomei stopped vomiting and bloody diarrhea after 2 days of treatment, and the blood routine returned to normal range on the 5th day. After 7 days of treatment, the dog recovered and was discharged from the hospital; the dog Pomeranian Liuliu stopped vomiting and bloody diarrhea after 4 days of treatment, and the blood routine returned to normal range on the 6th day. After 7 days of treatment, the dog recovered and was discharged from the hospital; the dog Bichon Xiong Er stopped vomiting and bloody diarrhea after 3 days of treatment, and the blood routine returned to normal range on the 6th day. After 7 days of treatment, the dog recovered and was discharged from the hospital; the dog Pastoral dog Pudding stopped vomiting and bloody diarrhea after 4 days of treatment, and the blood routine returned to normal range on the 5th day. After 7 days of treatment, the dog recovered and was discharged from the hospital.

[0107] In summary, the dogs in the western medicine group stopped vomiting in an average of 4.2 days, stopped bloody diarrhea in an average of 4.8 days, and blood routine returned to normal range in an average of 6.2 days. The dogs in the combination of Chinese and Western medicine group stopped vomiting in an average of 3.0 days, stopped bloody diarrhea in an average of 3.0 days, and blood routine returned to normal range in an average of 5.4 days. It can be seen that the oral liquid samples 1-3 prepared in Example 2 can shorten the time to stop vomiting and bloody diarrhea, and shorten the time for blood routine to return to normal.

[0108] The present invention effectively overcomes the deficiencies in the prior art and has a high industrial utilization value. The above embodiments are used to illustrate the substantive content of the present invention, but are not intended to limit the protection scope of the present invention. It should be understood by those skilled in the art that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and protection scope of the technical solution of the present invention.

Claims

1. A Chinese medicine composition for treating canine parvovirus disease, characterized in that: The weight composition is: 10-35 parts of Platycladus orientalis leaves, 10-35 parts of Portulaca oleracea, 10-35 parts of Andrographis paniculata, 10-25 parts of Sanguisorba officinalis, 10-25 parts of Scutellaria baicalensis, 10-25 parts of Pinellia ternata, 10-20 parts of Pueraria root, 10-15 parts of Sophora japonica flower, 10-15 parts of dried ginger, 5-15 parts of ginseng, and 5-15 parts of liquorice.

2. The Chinese medicine composition for treating canine parvovirus disease according to claim 1, characterized in that: The composition by weight is: 25-30 parts of Platycladus orientalis leaves, 25-30 parts of Portulaca oleracea, 25-30 parts of Andrographis paniculata, 15-20 parts of Sanguisorba officinalis, 15-20 parts of Scutellaria baicalensis, 15-20 parts of Pinellia ternata, 13-17 parts of Pueraria root, 10-15 parts of Sophora japonica flower, 10-15 parts of dried ginger, 5-10 parts of ginseng, and 5-10 parts of liquorice.

3. The extract of the Chinese medicine composition for treating canine parvovirus disease according to claim 1 or 2, characterized in that: include: (A) Andrographis paniculata extract, which is an ethanol extract of Andrographis paniculata, and the weight volume ratio of the ethanol extract of Andrographis paniculata to Andrographis paniculata is 1 ml:2 g; (B) Scutellaria baicalensis extract, which is a solution obtained by dissolving baicalin, a product of water extraction and acid precipitation of Scutellaria baicalensis, in 8 times the concentration of 50% by volume ethanol solution and adjusting the pH value to neutral, wherein the weight volume ratio of the solution to Scutellaria baicalensis is 1 ml:2 g; (C) Aqueous extracts of Platycladus orientalis leaves, Portulaca oleracea, Sanguisorba officinalis, Pinellia ternata, Pueraria root, Sophora japonica flower, Dry ginger, Ginseng, and Licorice, the weight volume ratio of the aqueous extract to the corresponding medicinal flavor being 1 ml:2 g; The Andrographis paniculata extract of component A and the Scutellaria baicalensis extract of component B are added to the water extract of component C, mixed evenly, and the pH value is adjusted to 5.5-6.0 to obtain the extract of the traditional Chinese medicine composition for treating canine parvovirus disease.

4. The extract of the Chinese medicine composition for treating canine parvovirus disease according to claim 3, characterized in that: The component A, the Andrographis paniculata extract, is extracted by the following steps: placing Andrographis paniculata in an 80% by volume ethanol solution for immersion extraction to obtain an immersion solution; concentrating the immersion solution under reduced pressure to 5% to 10% of the original volume, then decolorizing and filtering, and concentrating the filtrate under reduced pressure to obtain the Andrographis paniculata extract.

5. The extract of the Chinese medicine composition for treating canine parvovirus disease according to claim 4, characterized in that: The decolorization is carried out by heating activated carbon under reflux for 30 minutes, and the amount of activated carbon used is 10% to 20% of the weight of Andrographis paniculata.

6. The extract of the Chinese medicine composition for treating canine parvovirus disease according to claim 3, characterized in that: The scutellaria baicalensis extract of component B is prepared by the following steps: Add 8-10 times water to Scutellaria baicalensis and boil for 2 hours, filter; add 6-8 times water to the residue and boil for 2 hours, filter; combine the filtrates from the two decoctions, concentrate under reduced pressure to 5%-10% of the original volume, then filter and collect the filtrate, add acid to adjust the pH value to 1-2, keep warm at 80°C for 30 minutes, cool and precipitate crystals, and obtain crude baicalin; The crude baicalin was dissolved in 8 times water, the pH value was adjusted to 7, filtered, the filtrate was collected, acid was added to the filtrate to adjust the pH value to 1-2, the mixture was kept at 50°C for 30 minutes, cooled to precipitate crystals, and baicalin was obtained; Add 8 times the concentration of 50 V% ethanol solution to baicalin for dissolution, adjust the pH to 7, filter, collect the filtrate, and concentrate under reduced pressure to obtain the scutellaria baicalensis extract.

7. The extract of the Chinese medicine composition for treating canine parvovirus disease according to claim 3, characterized in that: The aqueous extract of component C is prepared by the following steps: taking Platycladus orientalis leaves, Portulaca oleracea, Sanguisorba officinalis, Pinellia tuber, Pueraria root, Sophora japonica flower, dried ginger, ginseng, and liquorice according to weight ratio, adding 8 to 10 times of water, decocting for 2 hours, and filtering; adding 6 to 8 times of water to the residues, decocting for 2 hours, and filtering; combining the filtrates of the two decoctions, and concentrating under reduced pressure to obtain the aqueous extract of component C.

8. A drug for treating canine parvovirus disease, characterized in that: The medicine is in the form of an oral liquid, comprising an extract of the Chinese medicine composition for treating canine parvovirus disease according to any one of claims 3 to 7 and pharmaceutically acceptable excipients.

9. The drug for treating canine parvovirus disease according to claim 8, characterized in that: The weight percentage composition of the medicine is: 1% to 3% of complex vitamin B, 5% to 20% of beef enzymatic hydrolysate, 0.3% of preservative, 0.1% of sweetener, and the rest is the extract of the traditional Chinese medicine composition for treating canine parvovirus disease.

10. The drug for treating canine parvovirus disease according to claim 9, characterized in that: The medicine is prepared by the following method: adding complex vitamin B, beef enzymatic hydrolysate, preservative and sweetener to the extract of the Chinese medicine composition for treating canine parvovirus disease, mixing, centrifuging to obtain the supernatant, and irradiating to sterilize, so as to obtain the medicine for treating canine parvovirus disease.

Citation Information

Patent Citations

  • Chinese medicinal composition for treating Canine parvovirus disease and preparation thereof

    CN101411762A

  • Preparation method of oral liquid for increasing immunity to muscovy duck parvovirus

    CN111067953A